Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Aaron Zhan"'
Autor:
Weiyun Z. Ai, Jonathan E. Brammer, Pierluigi Porcu, Frank McCormick, Lawrence K. Kaplan, Charalambos Andreadis, Basem M. William, Matthew J. Wieduwilt, Laura Pincus, Pamela Heeter, Wade Berry, Erika Cavallone, Aaron Zhan, Chen-Yen Yang, Chi-Heng Wu, Khoan Vu
Table S1, S2, S3, S4 Fig. S1, S2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5147379e8f8e968eeeb49d8e38d67438
https://doi.org/10.1158/1078-0432.22476672
https://doi.org/10.1158/1078-0432.22476672
Autor:
Weiyun Z. Ai, Jonathan E. Brammer, Pierluigi Porcu, Frank McCormick, Lawrence K. Kaplan, Charalambos Andreadis, Basem M. William, Matthew J. Wieduwilt, Laura Pincus, Pamela Heeter, Wade Berry, Erika Cavallone, Aaron Zhan, Chen-Yen Yang, Chi-Heng Wu, Khoan Vu
Purpose:The histone deacetylase (HDAC) inhibitor romidepsin and the anthracycline liposomal doxorubicin (LD) have modest single-agent activity in cutaneous T-cell lymphoma (CTCL) and peripheral T-cell lymphoma (PTCL). We investigated the safety and e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09e434c4487d5c150e5875623644f8fb
https://doi.org/10.1158/1078-0432.c.6529458.v1
https://doi.org/10.1158/1078-0432.c.6529458.v1
Autor:
Pamela Heeter, Erika Cavallone, Frank McCormick, Lawrence K. Kaplan, Laura B. Pincus, Wade Berry, Basem M. William, Aaron Zhan, Khoan Vu, Jonathan E. Brammer, Chen-Yen Yang, Charalambos Andreadis, Matthew J. Wieduwilt, Pierluigi Porcu, Weiyun Z. Ai, Chi-Heng Wu
Publikováno v:
Clinical Cancer Research. 26:1000-1008
Purpose: The histone deacetylase (HDAC) inhibitor romidepsin and the anthracycline liposomal doxorubicin (LD) have modest single-agent activity in cutaneous T-cell lymphoma (CTCL) and peripheral T-cell lymphoma (PTCL). We investigated the safety and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3bb55df541f8f4ab426bc850b557abc
https://doi.org/10.1158/1078-0432.ccr-19-2152
https://doi.org/10.1158/1078-0432.ccr-19-2152
Autor:
Andrew Muran, John Fallon, Byeongho Jung, Peter Dzaugis, Aaron Zhang, Michael Fitzgerald, Howard J. Goodman, Samuel Kenan, Shachar Kenan
Publikováno v:
Journal of Family Medicine and Primary Care, Vol 12, Iss 9, Pp 1979-1983 (2023)
Introduction: The management of benign bone lesions is controversial as it is dependent on a multitude of factors such as age, anatomic location, comorbidities, lesion metabolic activity, surgeon preferences, and goals of care, among others. Thus far
Externí odkaz:
https://doaj.org/article/642239575aa445eda69466531667687a